leisure time -WSS

leisure time

author：fashion 2025-10-04 03:40:28 - browse：94331

illustration of a colorful DNA strand, partly broken into pieces. -- health coverage from STAT — Adobe

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning.

In the study, run by Excision BioTherapeutics, researchers tried to use the gene editing tool to address a chief reason HIV has been so hard to cure. While antiviral drugs can clear patients of replicating virus, HIV is able to worm its way into a patients’ own DNA in certain cells. If the patient ever stops taking medicines, those cells start pumping out HIV particles and the infection roars back.

Researchers hoped they could send CRISPR to those cells and, by cutting the HIV DNA lurking there at two spots, slice out the virus. In the Phase 1 trial, investigators administered the treatment to five patients. They then took three of them off conventional antiviral treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： The Karikó problem: Lessons for funding basic research

explore

WSS

Condition critical? Britain's beloved but battered National Health Service turns 75

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

5 shark bites reported on Long Island as officials deploy surveillance drones

Some top drug companies are starting to take action on climate

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

The leaders of Italy and Poland say European Union should focus on stopping migration

explore

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

What does generative AI mean for health care? We asked experts

EU moves toward latest gene techniques in food production to counter climate change, shortages

What does generative AI mean for health care? We asked experts

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Malaria cases in Florida and Texas: Here’s what you need to know

Setback for rare diseases as Taysha Gene Therapies pulls back

ChatGPT in medicine: STAT answers readers' burning questions

Congress extends some pandemic preparedness programs

Medical leaders decry Supreme Court decision on affirmative action

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

hotspot

EU moves toward latest gene techniques in food production to counter climate change, shortages

Lawsuit highlights wrinkle for disputes over surprise medical bills

The United States is paying nearly triple for new Covid vaccines

Search warrant issued in 1996 disappearance of Kristin Smart

The stability of $0 premiums in Medicare Advantage

Study points to new risk in gene therapy death of Terry Horgan

explore

explore

Wikipedia

hotspot